Proteomic analysis of anti-tumor effects of 11-dehydrosinulariolide on CAL-27 cells

Marine Drugs

Volumn 9, Issue 7, 2011, Pages 1254-1272

  Liu, Chih I ^a   Chen, Cheng Chi ^a   Chen, Jiing Chuan ^a   Su, Jui Hsin ^b   Huang, Han Hsiang ^a   Chen, Jeff Yi Fu ^c   Wu, Yu Jen ^a  

^a MEIHO UNIVERSITY   (Taiwan)

^b NATIONAL MUSEUM OF MARINE BIOLOGY AND AQUARIUM   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

11 dehydrosinulariolide; CAL 27 cells; Proteomic analysis

Indexed keywords

11 DEHYDROSINULARIOLIDE; 40S RIBOSOMAL PROTEIN SA; ANTINEOPLASTIC AGENT; DJ 1 PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 60; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; INORGANIC PYROPHOSPHATASE; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE SUBUNIT ALPHA; LACTOGLUTATHIONE LYASE; NASCENT POLYPEPTIDE ASSOCIATED COMPLEX SUBUNIT ALPHA; NEUTRAL ALPHA GLUCOSIDASE AB PRECURSOR; NUCLEOLIN; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE A; PROHIBITIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A3; PURINE NUCLEOSIDE PHOSPHORYLASE; RETICULOCALBIN 1; RIBOSOME PROTEIN; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR PROTEIN; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINOL CYTOCHROME C REDUCTASE COMPLEX CORE PROTEIN 1; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; ENERGY METABOLISM; FUNCTIONAL PROTEOMICS; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FOLDING; UPREGULATION; WOUND HEALING;

ALCYONACEA; SINULARIA LEPTOCLADOS;

EID: 79960802282     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9071254     Document Type: Article

References (59)

1. Chen, Y.; Chang, J.; Liao, C.; Wang, H.; Yen, T.; Chiu, C.; Lu, Y.; Li, H.; Cheng, A. Head and neck cancer in the betel quid chewing area: Recent advances in molecular carcinogenesis. Cancer Sci. 2008, 99, 1507-1514.
2. Liao, C.; Chang, J.; Wang, H.; Ng, S.; Hsueh, C.; Lee, L.; Lin, C.; Chen, I.; Huang, S.; Cheng, A. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann. Surg. Oncol. 2008, 15, 915-922.
3. Liao, C.; Kang, C.; Chang, J.; Wang, H.; Ng, S.; Hsueh, C.; Lee, L.; Lin, C.; Cheng, A. Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol. 2007, 43, 811-819. (Pubitemid 47259447)
4. Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2002, 19, 1-48. (Pubitemid 34140331)
5. Ruggieri, G. Drugs from the sea. Science 1976, 194, 491-497.
6. Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 2001, 18, 1-49. (Pubitemid 32160982)
7. Ojika, M.; Islam, M.; Shintani, T.; Zhang, Y.; Okamoto, T.; Sakagami, Y. Three new cytotoxic acylspermidines from the soft coral, Sinularia sp. Biosci. Biotechnol. Biochem. 2003, 67, 1410-1412. (Pubitemid 39251842)
8. Ahmed, A.; Shiue, R.; Wang, G.; Dai, C.; Kuo, Y.; Sheu, J. Five novel norcembranoids from Sinularia leptoclados and S. parva. Tetrahedron 2003, 59, 7337-7344. (Pubitemid 37087988)
9. He, Q.; Chen, J.; Kung, H.; Yuen, A.; Chiu, J. Identification of tumor associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004, 4, 271-278. (Pubitemid 38140892)
10. Herrmann, P.C.; Liotta, L.; Petricoin, E.F., III. Cancer proteomics: The state of the art. Dis. Markers 2001, 17, 49-57.
11. Hsieh, P.W.; Chang, F.R.; McPhail, A.T.; Lee, K.H.; Wu, Y.C. New cembranolide analogues from the formosan soft coral Sinularia flexibilis and their cytotoxicity. Nat. Prod. Res. 2003, 17, 409-418.
12. Aceret, T.L.; Coll, J.C.; Uchio, Y.; Sammarco, P.W. Antimicrobial activity of the diterpenes flexibilide and sinulariolide derived from Sinularia flexibilis Quoy and Gaimard 1833 (Coelenterata: Alcyonacea, Octocorallia). Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 1998, 120, 121-126. (Pubitemid 28398894)
13. Rashid, M.A.; Gustafson, K.R.; Boyd, M.R. HIV-inhibitory cembrane derivatives from a Philippines collection of the soft coral Lobophytum species. J. Nat. Prod. 2000, 63, 531-533. (Pubitemid 30257170)
14. Ahmed, A.F.; Hsieh, Y.T.; Wen, Z.H.; Wu, Y.C.; Sheu, J.H. Polyoxygenated sterols from the Formosan soft coral Sinularia gibberosa. J. Nat. Prod. 2006, 69, 1275-1279.
15. Su, J.H.; Tseng, Y.J.; Huang, H.H.; Ahmed, A.F.; Lu, C.K.; Wu, Y.C.; Sheu, J.H. 9,11-Secosterols from the soft corals Sinularia lochmodes and Sinularia leptoclados. J. Nat. Prod. 2006, 69, 850-852.
16. Ahmed, A.F.; Tai, S.H.; Wu, Y.C.; Sheu, J.H. Sinugrandisterols AD, trihydroxysteroids from the soft coral Sinularia grandilobata. Steroids 2007, 72, 368-374.
17. Freedman, R.B.; Hirst, T.R.; Tuite, M.F. Protein disulphide isomerase: Building bridges in protein folding. Trends Biochem. Sci. 1994, 19, 331-336. (Pubitemid 24259985)
18. Hendershot, L. The ER function BiP is a master regulator of ER function. Mt. Sinai J. Med. 2004, 71, 289-297.
19. So, A.Y.L.; de la Fuente, E.; Walter, P.; Shuman, M.; Bernales, S. The unfolded protein response during prostate cancer development. Cancer Metastasis Rev. 2009, 28, 219-223.
20. Hartl, F.; Hlodan, R.; Langer, T. Molecular chaperones in protein folding: The art of avoiding sticky situations. Trends Biochem. Sci. 1994, 19, 20-25. (Pubitemid 24028727)
21. Guimaraes, A.J.; Frases, S.; Gomez, F.J.; Zancope-Oliveira, R.M.; Nosanchuk, J.D. Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect. Immun. 2009, 77, 1357-1367.
22. He, L.; Lemasters, J.J. Heat shock suppresses the permeability transition in rat liver mitochondria. J. Biol. Chem. 2003, 278, 16755-16760. (Pubitemid 36799542)
23. Ghosh, J.; Dohi, T.; Kang, B.; Altieri, D. Hsp60 regulation of tumor cell apoptosis. J. Biol. Chem. 2008, 283, 5188-5194.
24. Haas, I. BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum. Cell. Mol. Life Sci. 1994, 50, 1012-1020.
25. Hughes, C.; Shen, J.; Subjeck, J. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res. 1989, 49, 4452-4454. (Pubitemid 19208343)
26. Jamora, C.; Dennert, G.; Lee, A. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc. Natl. Acad. Sci. USA 1996, 93, 7690-7694. (Pubitemid 26277098)
27. Song, M.; Park, Y.; Lee, J.; Park, K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-ε/ERK/AP-1 signaling cascade. Cancer Res. 2001, 61, 8322-8330. (Pubitemid 33091628)
28. Pyrko, P.; Schonthal, A.H.; Hofman, F.M.; Chen, T.C.; Lee, A.S. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res. 2007, 67, 9809-9816. (Pubitemid 47621228)
29. Rao, R.V.; Hermel, E.; Castro-Obregon, S.; del Rio, G.; Ellerby, L.M.; Ellerby, H.M.; Bredesen, D.E. Coupling endoplasmic reticulum stress to the cell death program. J. Biol. Chem. 2001, 276, 33869-33874.
30. Honore, B.; Baandrup, U.; Vorum, H. Heterogeneous nuclear ribonucleoproteins F and H/H? show differential expression in normal and selected cancer tissues. Exp. Cell Res. 2004, 294, 199-209. (Pubitemid 38229792)
31. Fogel, B.L.; McNally, M.T. A cellular protein, hnRNP H, binds to the negative regulator of splicing element from Rous sarcoma virus. J. Biol. Chem. 2000, 275, 32371-32378.
32. Jacquenet, S.; Mereau, A.; Bilodeau, P.S.; Damier, L.; Stoltzfus, C.M.; Branlant, C. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J. Biol. Chem. 2001, 276, 40464-40475.
33. Oberg, D.; Fay, J.; Lambkin, H.; Schwartz, S. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J. Virol. 2005, 79, 9254-9269. (Pubitemid 40934837)
34. McNally, L.M.; Yee, L.; McNally, M.T. Heterogeneous nuclear ribonucleoprotein H is required for optimal U11 small nuclear ribonucleoprotein binding to a retroviral RNA-processing control element. J. Biol. Chem. 2006, 281, 2478-2488. (Pubitemid 43845707)
35. Garneau, D.; Revil, T.; Fisette, J.F.; Chabot, B. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 2005, 280, 22641-22650. (Pubitemid 40853168)
36. Crawford, J.B.; Patton, J.G. Activation of α-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F. Mol. Cell. Biol. 2006, 26, 8791-8802. (Pubitemid 44851939)
37. Yoshida, T.; Kokura, K.; Makino, Y.; Ossipow, V.; Tamura, T. Heterogeneous nuclear RNA-ribonucleoprotein F binds to DNA via an oligo (dG)-motif and is associated with RNA polymerase II. Genes Cells 1999, 4, 707-719. (Pubitemid 30053318)
38. Olopade, O.I.; Adeyanju, M.O.; Safa, A.R.; Hagos, F.; Mick, R.; Thompson, C.B.; Recant, W.M. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J. Sci. Am. 1997, 3, 230-237.
39. Clarke, M.F.; Apel, I.J.; Benedict, M.A.; Eipers, P.G.; Sumantran, V.; Gonzalez-Garcia, M.; Doedens, M.; Fukunaga, N.; Davidson, B.; Dick, J.E. A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc. Natl. Acad. Sci. USA 1995, 92, 11024-11028. (Pubitemid 3015310)
40. Montano, M.M.; Ekena, K.; Delage-Mourroux, R.; Chang, W.; Martini, P.; Katzenellenbogen, B.S. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc. Natl. Acad. Sci. USA 1999, 96, 6947-6952. (Pubitemid 29274990)
41. Sun, L.; Liu, L.; Yang, X.J.; Wu, Z. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation. J. Cell Sci. 2004, 117, 3021-3029. (Pubitemid 39117676)
42. Vander Heiden, M.G.; Choy, J.S.; VanderWeele, D.J.; Brace, J.L.; Harris, M.H.; Bauer, D.E.; Prange, B.; Kron, S.J.; Thompson, C.B.; Rudin, C.M. Bcl-x L complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism. J. Biol. Chem. 2002, 277, 44870-44876. (Pubitemid 36159082)
43. Fusaro, G.; Dasgupta, P.; Rastogi, S.; Joshi, B.; Chellappan, S. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 2003, 278, 47853-47861. (Pubitemid 37523233)
44. Rajalingam, K.; Wunder, C.; Brinkmann, V.; Churin, Y.; Hekman, M.; Sievers, C.; Rapp, U.R.; Rudel, T. Prohibitin is required for Ras-induced Raf-VMEK-VERK activation and epithelial cell migration. Nat. Cell Biol. 2005, 7, 837-843. (Pubitemid 41079057)
45. Nijtmans, L.G.J.; de Jong, L.; Sanz, M.A.; Coates, P.J.; Berden, J.A.; Back, J.W.; Muijsers, A.O.; van der Spek, H.; Grivell, L.A. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000, 19, 2444-2451. (Pubitemid 30323534)
46. Sanz, M.A.; Tsang, W.Y.; Willems, E.M.; Grivell, L.A.; Lemire, B.D.; van der Spek, H.; Nijtmans, L.G.J. The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans. J. Biol. Chem. 2003, 278, 32091-32099. (Pubitemid 37048398)
47. Lohrum, M.A.E.; Woods, D.B.; Ludwig, R.L.; Balint, E.; Vousden, K.H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 2001, 21, 8521-8532. (Pubitemid 33108611)
48. Mihara, M.; Erster, S.; Zaika, A.; Petrenko, O.; Chittenden, T.; Pancoska, P.; Moll, U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11, 577-590. (Pubitemid 36385115)
49. Chipuk, J.E.; Green, D.R. Cytoplasmic p53: Bax and forward. Cell Cycle 2004, 3, 429-431. (Pubitemid 40278229)
50. Mishra, S.; Murphy, L.C.; Nyomba, B.; Murphy, L.J. Prohibitin: A potential target for new therapeutics. Trends Mol. Med. 2005, 11, 192-197.
51. Trumpower, B.; Edwards, C.A. Purification of a reconstitutively active iron-sulfur protein (oxidation factor) from succinate. cytochrome c reductase complex of bovine heart mitochondria. J. Biol. Chem. 1979, 254, 8697.
52. Schapira, A.H.V.; Cooper, J.M.; Morgan-Hughes, J.A.; Landon, D.N.; Clark, J.B. Mitochondrial myopathy with a defect of mitochondrial-protein transport. N. Engl. J. Med. 1990, 323, 37-42. (Pubitemid 20209470)
53. Slipetz, D.; Aprille, J.; Goodyer, P.; Rozen, R. Deficiency of complex III of the mitochondrial respiratory chain in a patient with facioscapulohumeral disease. Am. J. Hum. Genet. 1991, 48, 502-510. (Pubitemid 21903048)
54. Fiskum, G.; Starkov, A.; Polster, B.M.; Chinopoulos, C. Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann. N. Y. Acad. Sci. 2003, 991, 111-119. (Pubitemid 36793807)
55. Gille, L.; Nohl, H. The ubiquinol/bc1 redox couple regulates mitochondrial oxygen radical formation. Arch. Biochem. Biophys. 2001, 388, 34-38. (Pubitemid 32911559)
56. Nicolay, K.; de Kruijff, B. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV. Biochim. Biophys. Acta Bioenerg. 1987, 892, 320-330.
57. Goormaghtigh, E.; Huart, P.; Brasseur, R.; Ruysschaert, J.M. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives. Biochim. Biophys. Acta Biomembr. 1986, 861, 83-94.
58. Tuquet, C.; Dupont, J.; Mesneau, A.; Roussaux, J. Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria. Cell Biol. Toxicol. 2000, 16, 207-219.
59. Huang, H.; Brennan, T.; Muir, M.; Mason, R. Functional α1 and β2 adrenergic receptors in human osteoblasts. J. Cell. Physiol. 2009, 220, 267-275.